Therapeutic Nuclear Medicines Sales Market - Forecast(2021 - 2026)
Therapeutic Nuclear Medicines Sales Market size is estimated at $1.6 billion in 2020, projected to grow at a CAGR of 7.3% during the forecast period 2021-2026. Therapeutic Nuclear Medicine is a pharmaceutical formulation containing radioactive materials. Cancer, metastatic bone tumors, and other disorders are treated with therapeutic nuclear medicines. Therapeutic nuclear drugs contain radioactive material that can destroy cancerous tissue, shrink tumors, and alleviate pain. Alpha Emitters, Beta Emitters and Brachytherapy Isotopes are the various types of therapeutic nuclear medicines. The rising incidence and prevalence of cancer and cardiac disorders, as well as measures to close the demand-supply gap for Mo-99 and radiopharmaceuticals are driving growth in the therapeutic nuclear medicines sales industry. Thyroid-related disorders like hyperthyroidism, respiratory diseases, bone diseases, and neurological diseases neuroblastoma are among the conditions for which research and studi...